The aim of this study was to determine if nitric oxide (NO) is the non-adrenergic, noncholinergic neurotransmitter, released by enteric inhibitory nerves, which mediates relaxation ofthe human internal anal sphincter. Isolated muscle strips were mounted for isometric tension recording in superfusion organ baths. Sodium nitroprusside, an exogenous donor of NO, relaxed the strips in a concentration dependent manner. In the presence of atropine and guanethidine, transmural field stimulation produced tetrodotoxin sensitive relaxations, which were inhibited in a dose dependent and enantiomer specific manner by antagonists of NO synthase; completely by L-nitroarginine and partially by L-N-monomethyl arginine. The effect of these antagonists was reversed by L-arginine but not D-arginine. Oxyhaemoglobin, a scavenger of nitric oxide, also abolished the relaxations but methaemoglobin had no such effect. These results strongly suggest that NO is, or is very closely associated with, the non-adrenergic, non-cholinergic neurotransmitter mediating neurogenic relaxation of the human internal anal sphincter. (Gut 1993; 34: 689-693) in nerve mediated relaxation of the internal anal sphincter.2"25
relaxation ofthe human internal anal sphincter. Isolated muscle strips were mounted for isometric tension recording in superfusion organ baths. Sodium nitroprusside, an exogenous donor of NO, relaxed the strips in a concentration dependent manner. In the presence of atropine and guanethidine, transmural field stimulation produced tetrodotoxin sensitive relaxations, which were inhibited in a dose dependent and enantiomer specific manner by antagonists of NO synthase; completely by L-nitroarginine and partially by L-N-monomethyl arginine. The effect of these antagonists was reversed by L-arginine but not D-arginine. Oxyhaemoglobin, a scavenger of nitric oxide, also abolished the relaxations but methaemoglobin had no such effect. These results strongly suggest that NO is, or is very closely associated with, the non-adrenergic, non-cholinergic neurotransmitter mediating neurogenic relaxation of the human internal anal sphincter. (Gut 1993; 34: 689-693) in nerve mediated relaxation of the internal anal sphincter. 2"25 Nitric oxide is synthesised from L-arginine in a reaction catalysed by NO synthase. This enzyme exhibits a high degree of substrate specificity (NO is not produced from Darginine) and is dependent on several cofactors, among which are Ca2+, calmodulin, and reduced nicotinamide adenine dinucleotide phosphate. Nitric oxide is freely soluble, diffuses rapidly, and has a short half life (three seconds), being inactivated by formation of NO3-after contact with the superoxide anion, 02-It exerts its effects by binding to cytosolic guanylate cyclase and stimulating the production of cyclic guanosine monophosphate.
In humans, the hypothesis that NO is an inhibitory neurotransmitter in the internal anal sphincter is based on results presented in a brief report,25 which showed that N-nitro-L-arginine, a potent antagonist of NO synthase, abolished NANC nerve mediated relaxation in isolated sphincter tissue. We have investigated the involvement of NO in greater detail and have examined the effects of exogenous NO, inhibitors ofNO synthase, and oxyhaemoglobin, a scavenger of NO, on the behaviour of isolated strips of human internal anal sphincter in vitro.
It has been recognised for over a century that the internal anal sphincter relaxes in response to rectal distension, a phenomenon called the rectanal inhibitory reflex. ' Krebs solution contained 120 mM NaCl, 5-9 mM KC1, 15-4 mM NaHCO3, 1 mM NaH2PO4, 2-5 mM CaCl, and 11 mM glucose. Solutions were equilibrated with 97% 02 and 3% CO2. Chemicals used were atropine sulphate and sodium nitroprusside (BDH Chemicals Ltd), D-arginine and L-arginine (Aldrich Chemical Company Inc), bovine haemoglobin, guanethidine monosulphate, N-monomethyl-D-arginine acetate, N-monomethyl-L-arginine acetate, N-nitro-L-arginine, and tetrodotoxin (all from Sigma Chemicals Co).
Oxyhaemoglobin was prepared as described previously,1* by reduction of bovine haemoglobin (Sigma) with sodium hydrosulphite (10-fold molar excess) followed by gel filtration with a prepacked disposable column (PD-10, Pharmacia), previously equilibrated with buffered Krebs solution. The concentration of oxyhaemoglobin was then determined spectrophotometrically (E576.=15 99 mM-1 cm-').
Methaemoglobin was made in a similar fashion, except that two fold molar excess of potassium ferricyanide was used instead of sodium hydrosulphite. 17 Where appropriate, results are expressed as mean (SEM), and statistical differences were assessed with the unpaired t test; a value of p<0 05 was considered to be significant. (3 x 10-6 M), a universal nerve toxin (Fig 2) . This confirmed that the relaxations were neurogenic and mediated by a NANC neurotransmitter.
RESPONSE TO INHIBITORS OF NO SYNTHASE
N-monomethyl-L-arginine and N-nitro-Larginine are synthetic analogues of L-arginine, and competive antagonists of NO synthase. Figure 3 shows their dose dependent inhibition of internal anal sphincter nerve mediated relaxation (induced by electrical field stimulation (n= 18)).
At a concentration of 5 xi0-M, N-monomethyl-L-arginine produced a partial but significant inhibition of the nerve mediated relaxations, reducing them to 72-4% (3-5%) of their original size (n=22) (p<0 05). Addition of D-arginine (5 x 10-4 M) had no effect upon this inhibition, but it was reversed by L-arginine at the same concentration (Fig 4) . N-monomethyl-D-arginine, the enantiomer (steroisomer) of Nmonomethyl-L-arginine, had no effect upon the tissue.
N-nitro-L-arginine is a more powerful antagonist of NO synthase. Its addition to the superfusate (10-5 M) abolished the response of the strips to electrical field stimulation (n=30) (Fig 5) . D-arginine (5 x 10' M) had no effect Oxyhaemoglobin has a high affinity for NO and scavenges it from extracellular media; methaemoglobin has no such action.2729 Addition of oxyhaemoglobin produced inhibition of nerve mediated relaxation in a dose dependent manner (n=6), and the neurogenic response was abolished at a concentration of 5 x 10-5 M (n=20) (Fig 6) . Relaxations returned after withdrawal ofoxyhaemoglobin and a period of recovery (Fig 6) . Methaemoglobin had no effect on the tissue. Conventional neurotransmitters such as acetylcholine and noradrenaline are stored in membrane bound vesicles before their release from presynaptic nerves, and they influence ig smooth muscle.25 To our knowledge however, the dose dependent effect of sodium nitroprusside, the enantiomeric specificity of the inhibition of NO synthase (and its reversal by substrates), and the action of oxyhaemoglobin have not been described in this tissue before. Rattan and coworkers have investigated the role ofNO in neurogenic relaxation ofthe internal anal sphincter in the opossum in vitro23 and have also assessed involvement of NO in the rectoanal inhibitory reflex in the same animal in vivo. 24 In both preparations, NO seems to play a crucial part as N-nitro-L-arginine has a profound antagonistic effect on inhibitory nerve stimulation. As in the human, this action is both dose and enantiomer specific. Although the opossum is phylogenically disparate from the human, these findings support our conclusions, particularly because they show the importance of NO in this region in vivo.
The immediate significance of establishing NO as the inhibitory neurotransmitter which mediates neurogenic relaxation of the human internal anal sphincter is that it will allow detailed study of the function and morphology of the intrinsic innervation of this tissue as well as its interaction with other components of the autonomic nervous system. These aspects of sphincter physiology can be assessed both in vitro and in vivo, and will not only improve our understanding of normal internal anal sphincter function, but will also shed new light on the pathophysiology of conditions such Hirschsprung's disease34 and idiopathic anorectal incontinence, in which the intrinsic innervation of the internal anal sphincter is known to be abnormal.35 Also, it may prove possible to manipulate NO neurotransmission pharmacologically, either inhibiting or enhancing it, and this could have important therapeutic implications in the management of disordered anorectal function.
